Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2007
11/01/2007US20070254942 1S)-Cyclopropanecarboxylic acid {7-chloro-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}amide, which may further contain an anticancer agent or an antiinflammatory agent; treating atopic dermatitis, Crohn's disease, and colon cancer
11/01/2007US20070254935 Pyrazole and imidazole compounds and uses thereof
11/01/2007US20070254924 Salts of benzimidazole compound and use thereof
11/01/2007US20070254923 Therapeutic salt compositions and methods
11/01/2007US20070254919 Aroyl-O-Piperidine Derivatives for the Treatment of Diabetes-Related Problems
11/01/2007US20070254918 Dopamine-, Norepinephrine- and Serotonin- Transporter-Selective Heterocyclic Compounds and Their Therapeutic Applications
11/01/2007US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007US20070254904 schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, pre-eclampsia, nociception, neuropathic pain, pancreatitis, neurogenic inflammation, asthma, chronic obstructive pulmonary disease (COPD) and urinary incontinence
11/01/2007US20070254903 Novel Spiroindoline or Spiroisoquinoline Compounds, Methods of Use and Compositions Thereof
11/01/2007US20070254894 Novel small molecules with selective cytotoxicity against human microvascular endothelial cell proliferation
11/01/2007US20070254888 Piperazinediones as Oxytocin Receptor Antagonists
11/01/2007US20070254881 Pyrazole Derivative
11/01/2007US20070254877 Indole Derivative and Use for Treatment of Cancer
11/01/2007US20070254874 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)
11/01/2007US20070254873 Chemical Compounds
11/01/2007US20070254868 such as 3-(1-(2,3-difluorophenyl)-1H-tetrazol-5-yl)-5-(4-(4-methylpiperazin-1-yl) phenyl)pyridin-2-amine, used as anticarcinogenic agents or for the treatment of atherosclerosis and lung fibrosis
11/01/2007US20070254867 Heterocyclic Kinase Inhibitors
11/01/2007CA2650057A1 Phenyl- or pyridinyl-amide as inhibitors of c-fms kinase
11/01/2007CA2649919A1 Phenyl-and pyridinyl amide inhibitors of c-fms kinase
11/01/2007CA2649762A1 Synthesis and uses of pyroglutamic acid derivatives
11/01/2007CA2649739A1 Inhibitors of c-fms kinase
11/01/2007CA2649736A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007CA2649636A1 Diazepan derivatives modulators of chemokine receptors
11/01/2007CA2649631A1 Vaccine against nicotine addiction
11/01/2007CA2649512A1 C-fms kinase inhibitors
11/01/2007CA2648809A1 Indazole compounds and methods for inhibition of cdc7
11/01/2007CA2646678A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007CA2646652A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007CA2646638A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
10/2007
10/31/2007EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors
10/31/2007EP1849781A1 Substituted 3-Amino-4-hydroxy pyrrolidines compounds, their preparation and use as medicaments
10/31/2007EP1849780A1 Vaccine against nicotine addiction
10/31/2007EP1849773A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative
10/31/2007EP1848715A1 Compounds having tie2 (tek) inhibitory activity
10/31/2007EP1848714A2 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
10/31/2007EP1848710A2 Heterocyclic substituted piperazines with cxcr3 antagonist activity
10/31/2007EP1848709A1 Novel salt form of a dopamine agonist
10/31/2007EP1848699A1 Anthranilic acid derivatives as hm74a receptor agonists
10/31/2007EP1848696A1 Imidazole and benzimidazole derivates useful as histamine h3 antagonists
10/31/2007EP1848694A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
10/31/2007EP1848435A2 Compounds for inflammation and immune-related uses
10/31/2007EP1848430A2 Novel benzylamine derivatives as cetp inhibitors
10/31/2007EP1848428A2 Thiazole amides, imidazole amides and related analogues
10/31/2007EP1755606B1 Quinazolinone derivatives useful as vanilloid antagonists
10/31/2007EP1636206B1 Imidazole derivatives as glutmate receptor antagonists
10/31/2007EP1534678B1 Pleuromutilin derivatives as antimicrobbials
10/31/2007EP1513821B1 Protein kinase inhibitors
10/31/2007EP1496896A4 Inhibitors of akt activity
10/31/2007EP1448551B1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007EP1242426B1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
10/31/2007EP1153013B1 5-ht1f agonists
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007CN101065375A Compounds, compositions containing them, preparations thereof and uses thereof
10/31/2007CN101065374A Substituted dipiperidine ccr2 antagonists
10/31/2007CN101065373A Metallic chromonic compounds
10/31/2007CN101065363A Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
10/31/2007CN101062919A 4-methyl-1H-diaryl pyrromonazole derivative and medicament usage thereof
10/31/2007CN100345844C Quinazoline derivatives for the treatment of tumours
10/31/2007CN100345843C Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
10/31/2007CN100345839C Reduced aminate of geniposide huperzine A and its preparation method and uses
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/30/2007US7288676 Arylphenyl-substituted cyclic ketoenols
10/30/2007US7288658 Process for preparation of pyridine derivatives
10/30/2007US7288652 Method for preparing oltipraz
10/30/2007US7288651 Such as (R)-4-bromo-N-[1-(2,4-dichlorophenyl)-ethyl]-2-(quinoxaline-5-quinoxaline-sulfonylamino)-benzamide via sulfonylation; cholecystokinin receptor modulators
10/30/2007US7288559 Carboxamide spirohydantoin CGRP receptor antagonists
10/30/2007US7288554 For agriculture crops
10/30/2007US7288552 Such as 4-[4-(benzhydryloxy)piperidino]butyl-4-nitrobenzoate
10/30/2007US7288549 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
10/30/2007US7288547 CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
10/30/2007US7288545 e.g., 3-[(5-benzyloxypyridin-2-yl)methylidene]-6-phenylmethylidene piperazine-2,5-dione; treating an angiogenesis-related disease.
10/30/2007US7288544 Calcium channel antagonistic activity; especially useful as analgesics
10/30/2007US7288542 viricides; therapy for genetic engineered virus; polymerase inhibitor
10/30/2007US7288541 Propylcarbamate derivatives as inhibitors of serine and cysteine proteases
10/30/2007US7288540 Phenylalkynes
10/30/2007US7288537 Azetidine derivatives as CCR-3 receptor antagonists
10/30/2007CA2421548C Amidine inhibitors of serine proteases
10/30/2007CA2416212C Indole derivatives useful for the treatment of cns disorders
10/30/2007CA2239227C Nitrogen-containing heterocyclic compounds
10/30/2007CA2179650C Bisindolemaleimides and their use as protein kinase c inhibitors
10/25/2007WO2007121389A2 4,4-disubstituted piperidine derivatives as nk-i and serotonin transporter inhibitors
10/25/2007WO2007120729A2 Pyridyl amide t-type calcium channel antagonists
10/25/2007WO2007120600A2 3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
10/25/2007WO2007120592A1 Cgrp antagonist salt
10/25/2007WO2007120574A2 Diaryl substituted alkanes
10/25/2007WO2007120102A1 New substituted oxindole derivatives
10/25/2007WO2007119889A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
10/25/2007WO2007119463A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/25/2007WO2007119055A1 Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
10/25/2007WO2007119046A1 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors
10/25/2007WO2007118903A1 Trisubstituted 1,2,4-triazoles
10/25/2007WO2007118900A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007WO2007118899A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007WO2007118819A2 Novel crystalline compounds
10/25/2007WO2007095188A3 Dihydrodiazepines useful as inhibitors of protein kinases
10/25/2007WO2007085954A3 Aminophthalazine derivative compounds
10/25/2007WO2007077508A3 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
10/25/2007WO2006033844A9 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators
10/25/2007US20070249833 such as 2-bromo-1-[6-(4-methyl-imidazole-1-yl)-pyridin-3-yl]-ethanone, which have activity in modulating levels of amyloid-beta, useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease
1 ... 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 ... 1080